Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06332560

Pain in Endometriosis And the Relation to Lifestyle

The goal of this clinical trial is to investigate the effect of an anti-inflammatory diet and cognitive behavioral therapy (CBT) on pain symptoms, health related quality of life and the effect on inflammatory characteristics in serum and menstruum samples as well as the effect on the gut and vaginal microbiome in women with endometriosis. In addition, we want to investigate the differences in stress (measured by hair cortisol levels), inflammatory markers in peripheral blood, menstrual effluent, and the vaginal and intestinal microbiome between persons without and with endometriosis. Participants will be randomized between standard care (control group), standard care and an anti-inflammatory diet intervention, or standard care, an anti-inflammatory diet intervention and CBT or CBT alone. Participants will follow an anti-inflammatory diet based on the Dutch Dietary Guidelines or CBT or a combination of both interventions for 12 weeks. They will receive personalized dietary advice from a dietician and recipes will be available. cognitive behavioral therapy will be administered in a total of seven individual sessions led by a psychotherapist. The content of these sessions will be psycho-education regarding pain mechanisms (and diet).

Recruiting

Interested in participating?

Request Info

Key information

Age range

17 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Jeroen Bosch Hospital (JBZ), 's-Hertogenbosch, Netherlands

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of endometriosis via ultrasound, MRI or surgery*
  • NRS pain score > 4*
  • Age from 17 years
  • Premenopausal status
  • Body Mass Index (BMI) 18-30 kg/m2
  • Ability to understand the explanation about the diet intervention (DI) and CBT*
  • Willing to follow the DI*
  • Willing to continue their use of food supplements
  • Willing to undergo CBT*
  • Willing to collect menstrual effluent, and therefore willing to have two stop weeks from hormonal contraception (if applicable) during the study period.

Exclusion criteria

  • Recurrent miscarriages (> 2)
  • Eating disorder
  • Diagnosed with Crohn's disease, Ulcerative Colitis, short bowel syndrome or another chronic inflammatory disease
  • Self-reported celiac disease
  • Vegan diet
  • Smoking
  • Use of immunosuppressive or psychotropic medication
  • Score on FFQ > 120
  • Diagnosed with severe mental disorder currently requiring treatment by psychiatrist
  • NRS average score below 4 during the last month
  • Participation in another intervention study
  • Unable to speak Dutch or to understand the intervention
  • Need for surgery during the participation in the study
  • Serious pain (NRS > 4) from other origin than endometriosis
  • Pregnant
  • Scalp hair shorter than 4 cm
  • Only applicable to patients with endometriosis

Treatment and study plan

Anti-inflammatory diet (DI)

Behavioral

12-week personalized dietary advice based on the Dutch Dietary Guidelines under the guidance of a dietician.

Other names: DI

Cognitive Behavioral Therapy (CBT)

Behavioral

Seven individual sessions led by a psychotherapist. The content of the CBT will be psycho-education regarding pain mechanisms and DI.

Other names: CBT

Primary outcomes

  1. Change in Pain intensity assessed by the Numerical Rating Scale

    Time frame: 3 months

    The Numerical Rating Scale (NRS) ranges from 0 (no pain) to 10 (unbearable pain), and is the most commonly used subjective measure to assess pain intensity. Patients will score there estimated average pain intensity and there highest pain intensity of the previous 7 days.

    Minimum value: 0 Maximum value: 10 Higher score indicates a higher level of pain intensity.

Secondary outcomes

  1. Change in health related quality of life assessed by the Endometriosis Health Profile 30

    Time frame: 3 months

    The Endometriosis Health Profile 30 (EHP-30) is a disease-specific QoL questionnaire which is validated for use in endometriosis patients and measures the impact of the disease on physical, mental and social aspects of life.

    The EHP-30 is not a numerical scale.

  2. Change in general quality of llife assessed by the Short Form 36

    Time frame: 3 months

    The Short Form 36 (SF-36) is a multipurpose, general health survey which is applied to measure QoL on nine different domains: physical functioning, social functioning, role limitations due to physical health, role limitations due to emotional problems, emotional well-being, vitality, pain, general health, and health change.

    The SF-36 is not a numerical scale.

  3. Change in inflammatory characteristics in menstruum

    Time frame: 3 months

    High-dimensional flow cytometry will be done to analyse immune cells such as T cells, B cells, monocytes, and macrophages. Also Naturel Killer (NK) cells will be analysed. Also in the menstruum, markers for (cluster of differentiation 56) CD56, (cluster of differentiation antigen 16) CD16, (killer immunoglobulin receptors)) KIR and (natural cytotoxicity receptors) NCR, and activation markers such as CD69 will be characterised.

  4. Change in inflammatory charecteristics in peripheral blood

    Time frame: 3 months

    High-dimensional flow cytometry will be done to analyse immune cells such as T cells, B cells, monocytes, and macrophages. Also NK cells will be analysed. Previous studies have described a key role for NK cells in endometriosis. A decreased percentage of NK cells was observed in peritoneal fluid of endometriosis patients compared to HC (Hoogstad-vanEvert et al., 2018 ). For in depth NK cell characterisation we will include markers for CD56, CD16, KIR (killer immunoglobulin receptors) and NCR (natural cytotoxicity receptors), and activation markers such as CD69.

  5. Change in soluble factors in plasma

    Time frame: 3 months

    Analysed with the Olink Proteomics 96 inflammatory panel and Luminex multiplex assay for important soluble factors in endometriosis, i.e. IFNy, TNFα, TNFβ, IL1, IL2, IL6, IL8, IL12 and IL15, VEGF, Granzyme B, and perforin.

  6. Change in the composition of vaginal and intestinal microbiome

    Time frame: 3 months

    Through 16S sRNA gene profiling the microbiome composition of faecal samples and vaginal swabs will be determined. Vaginal and faecal samples will be stored for later microbiome analysis if the the investigators see clear differences in inflammatory profiles after the dietary intervention.

  7. Change in objective stress assessed by measuring scalp hair cortisol levels

    Time frame: 3 months

    Cortisol will be extracted from hair. The researcher will carefully collect a scalp hair sample of at least 0,5 cm thickness and sent these to the laboratory to analyze. The most proximal part represents the most recently grown piece of hair. Hair samples will be cut into a segment corresponding to the 4 cm closest to the scalp, reflecting cortisol secretion over the four months prior to sample collection. Cortisol extraction from hair will be carried out using an enzyme-linked immunoassay (ELISA).

  8. Adherence and anti-inflammatory status of the diet

    Time frame: 3 months

    Diet quality will be assessed by the Eetscore. The Eetscore is a short (Food Frequency Questionnaire) FFQ, developed to assess the Dutch Healthy Diet 2015 (DHD2015) index. The questionnaire is composed of 40 questions assessing the frequency of consumption of food items. From the Eetscore FFQ, a DHD2015-index score can be calculated, indicating the diet quality of an individual.

    Ranges from 0 (unhealthy diet) - 160 (healthy diet).

Other outcomes

  1. Change in sleep quality assessed by the PSQI

    Time frame: 3 months

    Sleep quality will be assessed by a self-rated questionnaire called (Pittsburgh sleep quality index) PSQI. This questionnaire contains 19 items, generating scores for seven different components. A general score can be obtained by adding up the scores of the seven components. Currently, PSQI is the most used tool in clinical and research practice assessing sleep quality.

    Minimum score: 0. Maximum score: 21. Higher scores indicate worse sleep quality.

  2. Change in physical activity level assessed by the IPAQ-SF

    Time frame: 3 months

    Physical activity level will be assessed in this study to minimise confounding. Participants will fill in the (International Physical Activity Questionnaire Shor Form) IPAQ-SF, which is one of the most widely used self-report questionnaires assessing physical activity. This questionnaire assesses physical activity of the past seven days at four levels of intensity: vigorous, moderate, walking, and sitting.

    The IPAQ-SF sum score is expressed in PA Metabolic Equivalent of Task (MET)-minutes per day or week. A higher score corresponds to a physically more strenuous activity.

  3. Change in subjective stress assessed by the PSS

    Time frame: 3 months

    Perceived stress will be measured using the Perceived Stress Scale (PSS), a 10-item validated psychological instrument for measuring nonspecific perceived stress. Items are designed to score how unpredictable, uncontrollable, and overloaded respondents find their lives.

    Minimum value: 10. Maximum value: 50. Higher score indicates a higher level of perceived stress.

  4. Changes in pain cognitions assessed by the PASS

    Time frame: 3 months

    The Pain anxiety symptom scale (PASS) measures anxiety caused by pain. Questions are asked about feelings of fear of pain, cognitive anxiety, avoidance behaviour, and physiological anxiety symptoms.

    Minimum value: 0. Maximum value: 200. Higher score indicates a higher pain anxiety.

  5. Changes in pain cognitions assessed by the PCS

    Time frame: 3 months

    The pain catastrophizing Scale (PCS) measures the degree of pain catastrophizing of the participant by measuring elements of helplessness and pessimism in relation to the ability to cope with the pain experience.

    Minimum value: 0. Maximum value: 52. Higher score indicates a higher level of catastrophizing

  6. Changes in fatigue assessed by the CIS

    Time frame: 3 months

    The checklist Individual Strength (CIS) is a 20-item questionnaire addressing fatigue, concentration, motivation and activity over the past two weeks.

    The CIS is not a numerical scale.

  7. Anti-inflammatory diet rating

    Time frame: At the end of the intervention (3 months), when completed the diet intervention

    At the end of the intervention period, participants will evaluate the anti-inflammatory diet with a rating on scale, and several general questions concerning the taste, cost, and feasibility.

    Minimum value: 1 Maximum value: 10. Higher scores indicates greater satisfaction with the diet.

  8. Epigenetics

    Time frame: 3 months

    The global level of nucleosomes and the levels of nucleosome containing specific histone post-transcriptional modifications will be analyzed in menstrual effluent and/or K2-EDTA plasma samples from healthy patients (n=50) and from patients in the SC + DI and SC + DI + CBT group. DNA extraction from K2-EDTA plasma samples or from menstrual effluent, and DNA amount quantification and fragments length qualification Analysis of the samples will be performed using Nu.Q® immunoassays according to the instructions of the SME company Volition (Belgium), allowing for the quantification of specific nucleosome structures.

  9. Untargeted general plasma metabolomics

    Time frame: 3 months

    To measure metabolites, to understand the impact of both interventions on metabolic pathways

  10. Differences in inflammatory characteristics in menstruum and peripheral blood between patients with endometriosis and healthy controls

    Time frame: Baseline

    High-dimensional flow cytometry will be done to analyse immune cells such as T cells, B cells, monocytes, and macrophages. Also NK cells will be analysed. Previous studies have described a key role for NK cells in endometriosis. A decreased percentage of NK cells was observed in peritoneal fluid of endometriosis patients compared to HC (Hoogstad-vanEvert et al., 2018 ). For in depth NK cell characterisation we will include markers for CD56, CD16, KIR (killer immunoglobulin receptors) and NCR (natural cytotoxicity receptors), and activation markers such as CD69.

  11. Differences in the composition of vaginal and intestinal microbiome in patients with endometriosis and healthy controls

    Time frame: Baseline

    Through 16S sRNA gene profiling the microbiome composition of faecal samples and vaginal swabs will be determined.

  12. Differences in stress (measured by hair cortisol level) in patients with endometriosis and healthy controls

    Time frame: Baseline

    Cortisol will be extracted from hair. The researcher will carefully collect a scalp hair sample of at least 0,5 cm thickness and sent these to the laboratory to analyse. The most proximal part represents the most recently grown piece of hair. Hair samples will be cut into a segment corresponding to the 4 cm closest to the scalp, reflecting cortisol secretion over the four months prior to sample collection. Cortisol extraction from hair will be carried out using an enzyme-linked immunoassay (ELISA) (DRG Instruments GmbH, Marburg, Germany). Analysis of the samples will be performed according to the instructions of the ELISA kit manual at Biopsychology - TU Dresden (Germany).

Study contacts

Contact information is provided by the study sponsor or research team.

Emma Huijs

CONTACT

[email protected]

06-29698762

Sponsors and collaborators

Lead sponsor

Radboud University Medical Center

Other

Collaborators

  • ASSOCIATION OF PEOPLE WITH ENDOMETRIOSIS I AM 1 IN 10
  • Belgian Volition SRL
  • Biopsychology
  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain
  • Endometriosis UK
  • Horizon Europe
  • SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET
  • UNIWERSYTET MEDYCZNY W LUBLINIE
  • University College Cork
  • University of Bonn
  • University of Edinburgh
  • Université Catholique de Louvain
  • Wageningen University and Research
  • ZonMw: The Netherlands Organisation for Health Research and Development

Registry information

Official study title

Pain in Endometriosis And the Relation to Lifestyle: Effectiveness of a Dietary Intervention and Cognitive Behavioral Therapy in Endometriosis-associated Pain

Acronym: PEARL

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Mar 27, 2024
Registry last updated
Aug 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.